Search Results - "De Tassigny, A."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Compliance with treatment in Wilson's disease: On the interest of a multidisciplinary closer follow-up by Jacquelet, E, Beretti, J, De-Tassigny, A, Girardot-Tinant, N, Wenisch, E, Lachaux, A, Pheulpin, M-C, Poujois, A, Woimant, F

    Published in La revue de medecine interne (01-03-2018)
    “…Compliance with treatment is very important for patients who suffer from Wilson's disease, a rare genetic disorder. They can benefit a long-life and effective…”
    Get full text
    Journal Article
  2. 2

    Cognitive profile in Wilson's disease: A case series of 31 patients by Wenisch, É., De Tassigny, A., Trocello, J.-M., Beretti, J., Girardot-Tinant, N., Woimant, F.

    Published in Revue neurologique (01-12-2013)
    “…Wilson's disease (WD) is a rare autosomal recessive disorder of copper metabolism. If untreated, WD, which is initially a liver disease, can turn into a…”
    Get full text
    Journal Article
  3. 3

    Comparative Effects of Ionic and Nonionic Iodinated Low-Osmolar Contrast Media on Platelet Function with the PFA-100™ (Platelet Function Analyzer) by D’ANGLEMONT DE TASSIGNY, ALEXANDRA, IDéE, JEAN-MARC, COROT, AND CLAIRE

    Published in Investigative radiology (01-05-2001)
    “…D’Anglemont de Tassigny A, Idée J-M, Corot C. Comparative effects of ionic and nonionic iodinated low-osmolar contrast media on platelet function with the…”
    Get full text
    Journal Article
  4. 4
  5. 5

    L’observance dans la maladie de Wilson : intérêt d’un suivi rapproché au long cours by Jacquelet, E., Beretti, J., De-Tassigny, A., Girardot-Tinant, N., Wenisch, E., Lachaux, A., Pheulpin, M.-C., Poujois, A., Woimant, F.

    Published in La revue de medecine interne (01-03-2018)
    “…L’observance dans la maladie de Wilson, pathologie génétique rare, est cruciale. Il existe des traitements efficaces si prescrits précocement et pris à vie…”
    Get full text
    Journal Article
  6. 6

    Volume-sensitive chloride channels (ICl,vol) mediate doxorubicin-induced apoptosis through apoptotic volume decrease in cardiomyocytes by D'Anglemont De Tassigny, Alexandra, Souktani, Rachid, Henry, Patrick, Ghaleh, Bijan, Berdeaux, Alain

    Published in Fundamental & clinical pharmacology (01-10-2004)
    “…Apoptosis is associated with early changes in cell volume through a mechanism called apoptotic volume decrease (AVD). As volume‐sensitive chloride channels…”
    Get full text
    Journal Article
  7. 7
  8. 8

    HYPO-OSMOTIC STRESS INHIBITS DOXORUBICIN-INDUCED APOPTOSIS VIA A PROTEIN KINASE A-DEPENDENT MECHANISM IN CARDIOMYOCYTES by D'Anglemont De Tassigny, Alexandra, Ghaleh, Bijan, Souktani, Rachid, Henry, Patrick, Berdeaux, Alain

    “…SUMMARY 1. The clinical use of doxorubicin is limited by the development of severe cardiomyopathies linked, at least in part, to an abnormal increase in the…”
    Get full text
    Journal Article
  9. 9

    Inhibitors of swelling-activated chloride channels increase infarct size and apoptosis in rabbit myocardium by Souktani, Rachid, Ghaleh, Bijan, Tissier, Renaud, De Tassigny, Alexandra d'Anglemont, Aouam, Karim, Bedossa, Pierre, Charlemagne, Danièle, Samuel, Janelyse, Henry, Patrick, Berdeaux, Alain

    Published in Fundamental & clinical pharmacology (01-10-2003)
    “…Apoptosis is a significant contributor to myocardial cell death during ischemia‐reperfusion and swelling‐activated chloride channels (ICl,swell) contribute to…”
    Get full text
    Journal Article